Imperial College London

ProfessorMaudLemoine

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Professor and Honorary Consultant in Hepatology
 
 
 
//

Contact

 

+44 (0)20 3312 5212m.lemoine

 
 
//

Location

 

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Summary

Dr Maud Lemoine is Professor and Honorary Consultant in Hepatology at St Mary’s hospital, Imperial College London, UK. She completed her medical degree and PhD in Paris, France. She also graduated in political sciences from the Institute of Political Studies in Paris. Her research activities are mainly focused on the prevention and management of viral hepatitis in resource-limited countries, mainly in Africa. Since 2011, she has been working with the Medical Research Council (MRC) The Gambia unit, as part of the hepatitisB PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa) programme in The Gambia and Senegal. She has been member of the WHO guideline development group for the management of chronic hepatitis B/C and is regularly commissioned by the WHO viral hepatitis unit for external reviews and consultancies

Funding: MRC UK, Wellcome Trust, ANRS, Gilead US and Viiv healthcare

Links: http://www.mrc.gm/screen-and-treat-scheme-for-hepatitis-b-may-prevent-deadly-complications-29-jul-2016/

Follow on twitter: @maud_lemoine

Publications

Journals

Lemoine M, Cooke GS, Thursz M, et al., 2021, Cuts to UK official development assistance budget jeopardise global viral hepatitis elimination goals., Lancet Gastroenterol Hepatol, Vol:6, Pages:527-528

Post G, Howell J, Sow A, et al., 2021, Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B, Journal of Viral Hepatitis, Vol:28, ISSN:1352-0504, Pages:1003-1010

Kim JU, Ingiliz P, Shimakawa Y, et al., 2021, Improving care of migrants is key for viral hepatitis elimination in Europe, Bulletin of the World Health Organization, Vol:99, ISSN:0042-9686, Pages:280-286

Scott N, Mohamed Z, Rwegasha J, et al., 2021, Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model, International Journal of Drug Policy, Vol:88, ISSN:0955-3959

Yoshida K, Desbiolles A, Feldman SF, et al., 2021, Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants, Clinical Gastroenterology and Hepatology, Vol:19, ISSN:1542-3565, Pages:46-+

More Publications